AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 167 filers reported holding AKEBIA THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $979,000 | -41.6% | 433,400 | -25.5% | 0.08% | -37.5% |
Q3 2021 | $1,675,000 | -24.4% | 581,700 | -0.5% | 0.12% | -17.8% |
Q2 2021 | $2,216,000 | +8.2% | 584,600 | -3.4% | 0.15% | -0.7% |
Q1 2021 | $2,048,000 | +447.6% | 605,100 | +794.7% | 0.15% | +600.0% |
Q4 2018 | $374,000 | -25.5% | 67,634 | +18.9% | 0.02% | 0.0% |
Q3 2018 | $502,000 | – | 56,886 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alerce Investment Management, L.P. | 4,652,561 | $1,471,000 | 1.42% |
Orchard Capital Management, LLC | 251,826 | $80,000 | 0.03% |
GSA CAPITAL PARTNERS LLP | 486,568 | $154,000 | 0.02% |
Icon Wealth Advisors, LLC | 400,132 | $127 | 0.02% |
ACADIAN ASSET MANAGEMENT LLC | 7,483,053 | $2,365,000 | 0.01% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 2,042,816 | $646,000 | 0.01% |
WIPFLI FINANCIAL ADVISORS LLC, | 200,000 | $63,000 | 0.00% |
WEALTH EFFECTS LLC | 18,316 | $6,000 | 0.00% |
James J. Burns & Company, LLC | 25,142 | $8,000 | 0.00% |
Bayesian Capital Management, LP | 68,600 | $22,000 | 0.00% |